This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.



Drug Names(s): XPro1595

Description: XPro1595 is a dominant negative inhibitor of TNF alpha.

Deal Structure: XPro1595 was discovered and developed at Xencor.

In April 2012, FPRT Bio entered into a world-wide license agreement for the use of XPro1595 from Xencor.

Partners: Xencor, Inc.

XPro1595 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug